Clinical Trial Update: Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension) [Phase 1]

View source ↗

Summary

Phase 1 extension evaluating patupilone's effect on the pharmacokinetics of midazolam and omeprazole in patients with advanced solid tumors has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Midazolam (Midazolam)
• Omeprazole (Omeprazole)
• Patupilone (epothilone B)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Solid Tumors | Phase 1 | Status: WITHDRAWN